Showing 2461-2470 of 3137 results for "".
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://modernaesthetics.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform
- Skin of Color Society Media Day Analyzes Latest Trendshttps://modernaesthetics.com/news/skin-of-color-society-media-day-analyzes-latest-trends/2484533/In an era of misinformation and viral skincare fads, the Skin of Color Society’s (SOCS) 8th Annual Media Day offered a timely and authoritative voice, gathering top board-certified dermatologists to address critical dermatologic topics relevant to patients with skin of color. From trending TikTok
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca
- Systematic Review Examines Hematoma Reduction Techniques in Faceliftshttps://modernaesthetics.com/news/systematic-review-examines-hematoma-reduction-techniques-in-facelifts/2484473/A new systematic review and meta-analysis published in Facial Plastic Surgery & Aesthetic Medicine underscores the incidence of hematoma after rhytidectomy and evaluates commonly used adjunctive techniques aimed at reducing this complication. The analysis focused on patients undergoi
- VISTA Trial Validates Noninvasive Tool for Skin Feature Identificationhttps://modernaesthetics.com/news/vista-trial-validates-noninvasive-tool-for-skin-feature-identification/2484391/A novel imaging system may offer dermatologists a noninvasive alternative to assess histologic skin features, according to results from the VISTA Trial published in JAMA Dermatology. The multisite trial evaluated Enspectra Health’s VIO handheld cross-modal imaging system, which in
- Facial Aesthetic Surgical Training May Lag Behind Market Demand, Study Findshttps://modernaesthetics.com/news/facial-aesthetic-surgical-training-may-lag-behind-market-demand-study-finds/2484290/A new analysis published in the Journal of Plastic, Reconstructive & Aesthetic Surgery suggests that US plastic surgery residency programs may not be fully aligned with procedural trends in the growing facial aesthetics market. The study compares Accreditation Council for Graduate Me
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://modernaesthetics.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- Neutrogena Recalls Makeup Wipes Due to Bacterial Contaminationhttps://modernaesthetics.com/news/neutrogena-recalls-makeup-wipes-due-to-bacterial-contamination/2484214/The Food and Drug Administration (FDA) issued a Class II risk level for a line of Neutrogena's makeup-removing facial wipes due to potential bacterial infection, according to a statement from the agency. In a brief message, the FDA reported that an internal investigation by the manufacture
- CollPlant Launches US Logistics Hub to Support North American Growthhttps://modernaesthetics.com/news/collplant-launches-us-logistics-hub-to-support-north-american-growth/2484120/CollPlant Biotechnologies has expanded its North American operations through a new partnership with a US-based logistics hub, the company announced. The center, expected to become operational this quarter, will support the growing distribution needs for CollPlant’s recombinant human collagen (rhC
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://modernaesthetics.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.